Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-26 Purchase | 2024-03-28 7:04 pm | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 395,317 | $8.6654 | $3,425,569 | 3,753,480 (Indirect) | View |
2023-12-13 Purchase | 2023-12-15 5:32 pm | IGM Biosciences Inc. | IGMS | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 532,693 | $6.4417 | $3,431,464 | 3,390,323 (Indirect) | View |
2023-12-13 Purchase | 2023-12-14 6:10 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 101,792 | $221.2 | $22,516,577 | 1,793,403 (Indirect) | View |
2023-12-12 Purchase | 2023-12-14 6:09 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 34,578 | $218.31 | $7,548,616 | 1,699,129 (Indirect) | View |
2023-11-21 Purchase | 2023-11-21 6:15 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 64,350 | $188.47 | $12,128,340 | 1,667,104 (Indirect) | View |
2023-11-17 Purchase | 2023-11-21 6:14 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 67,079 | $178.11 | $11,947,280 | 1,607,668 (Indirect) | View |
2023-11-14 Purchase | 2023-11-15 5:13 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 49,387 | $158.13 | $7,809,559 | 1,545,775 (Indirect) | View |
2023-11-13 Purchase | 2023-11-15 5:12 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 107,499 | $146.99 | $15,801,021 | 1,500,227 (Indirect) | View |
2023-10-19 Sale | 2023-10-23 4:49 pm | Atreca Inc. | BCEL | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Former 10% Owner | 274,739 | $0.4025 | $110,582 | 2,971,128 (Indirect) | View |
2023-08-15 Purchase | 2023-08-17 5:08 pm | Neoleukin Therapeutics Inc. | NLTX | BAKER BROS. ADVISORS LP 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Director 10% Owner | 2,285,342 | $0.64038 | $1,463,487 | 5,617,469 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion